Budesonide Inhalation Suspension for Acute Asthma in Children
Status:
Completed
Trial end date:
2007-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the addition of budesonide inhalation
suspension (BIS) to the standard therapy of albuterol, ipratropium bromide, and systemic
corticosteroids (SCS) for moderate to severe asthma flares in children reduces asthma
severity more rapidly than standard therapy alone.